P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL
P1530:输血期C1抑制剂治疗重症补体介导的自身免疫性溶血性贫血患者:一项开放标签的II期试验
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.1091668
Schriek, Angela I; van Haaren, Marlies M; Poniman, Meliawati; Dekkers, Gillian; Bentlage, Arthur E H; Grobben, Marloes; Vidarsson, Gestur; Sanders, Rogier W; Verrips, Theo; Geijtenbeek, Teunis B H; Heukers, Raimond; Kootstra, Neeltje A; de Taeye, Steven W; van Gils, Marit J; de Boer, E C W; Jalink, M; Delvasto-Nuñes, L; Meulenbroek, E M; Baas, I; Janssen, S R; Dijkman, E E; Gelderman, K A; Wouters, D; Engel, M D; de Haas, M; Kersten, M-J; Jongerius, I; Zeerleder, S; Vos, J M